SERCA Pump Inhibitors Do Not Correct Biosynthetic Arrest of ΔF508 CFTR in Cystic Fibrosis

Deletion of phenylalanine 508 (ΔF508) accounts for nearly 70% of all mutations that occur in the cystic fibrosis transmembrane conductance regulator (CFTR). The ΔF508 mutation is a class II processing mutation that results in very little or no mature CFTR protein reaching the apical membrane and thu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Grubb, Barbara R., Gabriel, Sherif E., Mengos, April, Gentzsch, Martina, Randell, Scott H., Van Heeckeren, Anna M., Knowles, Michael R., Drumm, Mitchell L., Riordan, John R., Boucher, Richard C.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Thoracic Society 2006
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2644200/
https://ncbi.nlm.nih.gov/pubmed/16284361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2005-0286OC
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares